VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $218,000 | -40.8% | 14,995 | 0.0% | 0.12% | +43.8% |
| Q3 2016 | $368,000 | +16.5% | 14,995 | -4.5% | 0.08% | -48.4% |
| Q2 2016 | $316,000 | -23.5% | 15,695 | 0.0% | 0.16% | -20.1% |
| Q1 2016 | $413,000 | -67.5% | 15,695 | +25.6% | 0.19% | -66.8% |
| Q4 2015 | $1,270,000 | -30.9% | 12,495 | +21.3% | 0.58% | -33.7% |
| Q3 2015 | $1,837,000 | +96.9% | 10,300 | +145.2% | 0.88% | +86.3% |
| Q2 2015 | $933,000 | – | 4,200 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |